Antoni C. Picornell

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

José Á. García-Sáenz, Sara López‐Tarruella, Hugo Fuentes, Qamar J. Khan et autres

PURPOSE: Prognostic value of pathologic complete response (pCR) and extent of pathologic response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) is unknown. We report recurrence-free survival (RFS) and overall survival (OS) according to degree of …

us (code pays fourni par la source)

Supplemental Material Description from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Claire Ward et autres

Supplemental material contains names of participating institutions for the Spanish MMJ-CAR-2014-01 cohort, details on local guidelines for positive family history, tables depicting the relationship between pathological response and family history, pathological response and ER/PR status and univariate analysis of predictors of RCB …

Table S1 from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Isabel Echavarría, Sara López‐Tarruella, Antoni C. Picornell, José Á. García-Sáenz et autres

Table S1 Response among mutation carriers among mutation carriers (number of patients.)

Supplementary Material from Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment

A. Masson-Lecomte, Evangelina López de Maturana, Michael E. Goddard, Antoni C. Picornell et autres

Supplementary methods, tables and figures

Supplemental Material Description from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Claire Ward et autres

Supplemental material contains names of participating institutions for the Spanish MMJ-CAR-2014-01 cohort, details on local guidelines for positive family history, tables depicting the relationship between pathological response and family history, pathological response and ER/PR status and univariate analysis of predictors of RCB …

Table S1 from Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Isabel Echavarría, Sara López‐Tarruella, Antoni C. Picornell, José Á. García-Sáenz et autres

Table S1 Response among mutation carriers among mutation carriers (number of patients.)

Figure S2 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Qamar J. Khan et autres

Recurrence-free survival and overall survival in the overall patient population

Figure S1 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Qamar J. Khan et autres

Pathological response to carboplatin plus docetaxel by germline BRCA status

Figure S3 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Qamar J. Khan et autres

Recurrence-free survival and overall survival by adjuvant chemotherapy use in RCB II/III patients

Supplementary Methods and Results from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Qamar J. Khan et autres

Further description of patient population and exploratory analysis.

Data from Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment

A. Masson-Lecomte, Evangelina López de Maturana, Michael E. Goddard, Antoni C. Picornell et autres

Abstract Background: Increasing evidence points to the role of tumor immunologic environment on urothelial bladder cancer prognosis. This effect might be partly dependent on the host genetic context. We evaluated the association of SNPs in inflammation-related genes with non–muscle-invasive bladder cancer (NMIBC) …

Data from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Claire Ward et autres

Abstract Purpose: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin to anthracycline/taxane chemotherapy improves pathologic complete response (pCR) in triple-negative breast cancer (TNBC). Effectiveness of anthracycline-free platinum combinations in TNBC is not well known. Here, we report efficacy of NA carboplatin …